Characterization of wild-type and mutant α2-antiplasmins: Fibrinolysis enhancement by reactive site mutant

Blood

Volumn 94, Issue 1, 1999, Pages 164-171

  Lee, Kyung N ^a,b   Tae, Weon Chan ^a   Jackson, Kenneth W ^a   Kwon, Soon H ^a   McKee, Patrick A ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b WK Warren Medical Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; FIBRIN; MUTANT PROTEIN; PLASMIN;

ALPHA CHAIN; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; COVALENT BOND; CROSS LINKING; FIBRINOLYSIS; NONHUMAN; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0033168337     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.1.164.413k16_164_171     Document Type: Article

References (31)

1. 2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem 251:5956, 1976
2. 2-antiplasmin. Eur J Biochem 166:565, 1987
3. 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. J Biol Chem 257:14767, 1982
4. 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest 69:536, 1982
5. 2-antiplasmin enhances in vivo thrombolysis. Circulation 82:164, 1990
6. Schechter I, Berger A: On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27:157, 1967
7. 2-antiplasmin. J Biol Chem 262:6055, 1987
8. 2-antiplasmin on urokinase-induced fibrinolysis. Thromb Haemost 80:637, 1998
9. 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive site. Biochemistry 26:5133, 1987
10. 2-plasmin inhibitor. J Biochem 106:703, 1989
11. Cregg JM, Vedvick TS, Raschke WC: Recent advances in the expression of foreign genes in Pichia pastoris. Biotechnology 11:905, 1993
12. 2-antiplasmin with chicken IgY specific to its carboxy-terminal peptide. Prep Biochem Biotech 27:227, 1997
13. Folk JE, Chung SI: Transglutaminases. Methods Enzymol 113: 358, 1985
14. Wiman B, Collen D: Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma. Eur J Biochem 78:19, 1977
15. Schwartz ML, Pizzo SV, Hill RL, McKee PA: Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem 248:1395, 1973
16. Rashtchian A: Novel methods for cloning and engineering genes using the polymerase chain reaction. Curr Opin Biotech 6:30, 1995
17. Scorer CA, Clare JJ, McCombie WR, Romanos MA, Sreekrishna K: Rapid selection using G418 of high copy number transformants of Pichia pastoris for high-level foreign gene expression. Biotechnology 12:181, 1994
18. 2-antiplasmin: Binding to native and modified antigens. Thromb Res 45:485, 1987
19. Lee KN, Fesus L, Yancey ST, Girard JE, Chung SI: Development of selective inhibitors of transglutaminase: Phenylthiourea derivatives. J Biol Chem 260:14689, 1985
20. Beebe DP, Aronson DL: An automated fibrinolytic assay performed in microtiter plates. Thromb Res 47:123, 1987
21. Jones AJ, Meunier AM: A precise and rapid microtitre plate clot lysis assay: Methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Thromb Haemost 64:455, 1990
22. 2-antiplasmin: Implications for the structural and functional properties. Biochem J 323:847, 1997
23. Moerschell RP, Hosokawa Y, Tsunasawa S, Sherman F: The specificities of yeast methionine aminopeptidase and acetylation of amino-terminal methionine in vivo. Processing of altered iso-1-cytochromes c created by oligonucleotide transformation. J Biol Chem 265:19638, 1990
24. 2-plasmin inhibitor. Proc Natl Acad Sci USA 76:2013, 1979
25. 1-antichymotrypsins. J Biol Chem 265:1199, 1990
26. 1-antitrypsin expressed as inclusion bodies in Escherichia coli: Characterization of aggregation. Biochim Biophys Acta 1247:179, 1995
27. Hopkins PC, Crowther DC, Carrell RW, Stone SR: Development of a novel recombinant serpin with potential antithrombotic properties. J Biol Chem 270:11866, 1995
28. 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochim Biophys Acta 661:280, 1981
29. 2-plasmin inhibitor to fibrin. FEBS Lett 153:369, 1983
30. 2-plasmin inhibitor. Blood 66:157, 1985
31. Urano T, Sakakibara K, Rydzewski A, Urano S, Takada Y, Takada A: Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor I. Thromb Haemost 63:82, 1990